Susquehanna International Group
TCBPW

Susquehanna International Group’s TC BioPharm (Holdings) plc Warrants TCBPW Stock Holding History

Susquehanna International Group’s Portfolio TCBPW Stock Details TCBPW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-37,609
Closed -$504 – 13273
2024
Q2 		$504 Buy
+37,609
New +$628 ﹤0.01% 11881
2024
Q1 		– Sell
-11,406
Closed -$297 – 13601
2023
Q4 		$297 Buy
+11,406
New +$267 ﹤0.01% 12226
2023
Q2 		– Sell
-14,174
Closed -$1.41K – 13361
2023
Q1 		$1.41K Buy
+14,174
New +$1.79K ﹤0.01% 12397

Other funds holding TCBPW

KC
Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
CAG
Csenge Advisory Group Clearwater, Florida $2.18B AUM 16.73% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Susquehanna International Group's TCBPW Position: Q3 2024 in Review

Susquehanna International Group sold out of TC BioPharm (Holdings) plc Warrants (TCBPW) in Q3 2024, closing a stake of 37,609 shares — an estimated $504 sold.

Susquehanna International Group first reported a position in TCBPW in Q1 2023 and held it in 3 quarters. The position peaked at $1.41K in Q1 2023. 6 funds tracked by Wall St. Rank hold TCBPW as of Q3 2024.

  • Susquehanna International Group reported no remaining TC BioPharm (Holdings) plc Warrants position as of Q3 2024 after selling out during the quarter.
  • Susquehanna International Group sold 37,609 TC BioPharm (Holdings) plc Warrants shares in Q3 2024, an estimated $504.
  • Susquehanna International Group first reported a position in TC BioPharm (Holdings) plc Warrants in Q1 2023 and held it in 3 quarters.
  • Susquehanna International Group's TC BioPharm (Holdings) plc Warrants position peaked at $1.41K in Q1 2023.
  • 6 funds tracked by Wall St. Rank held TC BioPharm (Holdings) plc Warrants as of Q3 2024.

Based on Susquehanna International Group's 13F filing for Q3 2024, filed 14 Nov 2024.